Molecular Pathology in Cancer: Targeting Biomarkers for Early Diagnosis and Personalized Treatment

Abstract

Molecular pathology plays a pivotal role in the understanding, diagnosis, and treatment of

cancer. With the advent of molecular techniques, cancer biomarkers have emerged as critical

tools for the early detection of malignancies and the development of personalized therapeutic

strategies. This paper explores the significance of molecular pathology in cancer, focusing on

the identification of specific biomarkers and their applications in both diagnosis and

treatment. It further discusses the potential of biomarkers to enhance the accuracy of early

detection and enable the tailoring of individualized treatment plans, ultimately improving

patient outcomes. The integration of molecular pathology into clinical practice holds great

promise for revolutionizing cancer care, though challenges such as biomarker validation,

standardization, and cost remain.